Srs Capital Advisors, Inc. Dr Reddys Laboratories LTD Transaction History

Srs Capital Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$29.25 - $36.73 $3,129 - $3,930	-107 Closed	0 $0
Q2 2018 Aug 21, 2018	SELL	$28.49 - $35.06 $1,994 - $2,454	-70 Reduced 39.55%	107 $3,000
Q1 2018 May 14, 2018	BUY	$31.93 - $39.54 $925 - $1,146	29 Added 19.59%	177 $5,000
Q4 2017 Feb 15, 2018	BUY	$34.15 - $37.62 $2,458 - $2,708	72 Added 94.74%	148 $5,000
Q3 2017 Nov 15, 2017	BUY	$30.11 - $37.72 $2,288 - $2,866	76	76 $2,000

243

23.2M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.34B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.